Alex Phillips

1.3k citations
5 papers · 953 · 2 hit papers · h-index 4

Impact in

Papers in

Alex Phillips

5 papers receiving 907 citations

Alex Phillips's Hit Papers

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial 2022 · 282 citations
2820+1+3Years since publication100200300400

Peers

Alex Phillips
Comparison fields: 5 of 70
  • Infectious Diseases 706
  • Applied Microbiology and Biotechnology 34
  • Internal Medicine 27
  • Hematology 29
  • Oncology 48
Replace Andrew Rees with:
Andrew Rees United Kingdom
Cecillia Rafique United Kingdom
Paul Dmitri United Kingdom
Benjamin Rowlands United Kingdom
Khalid Rashid Pakistan
Beth Sage United Kingdom
Alkesh Patel United Kingdom
Joanna Pickles United Kingdom
Michael Pynn United Kingdom
Jean Patrick United Kingdom
Alex Phillips relative to Andrew Rees United Kingdom Andrew Rees's profile →
Citations per field
00.5×1.5×
Andrew Rees · 1×
Citations per year

Countries citing papers authored by Alex Phillips

Since Specialization
Citations

This map shows the geographic impact of Alex Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Phillips more than expected).

Fields of papers citing papers by Alex Phillips

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Phillips. The network helps show where Alex Phillips may publish in the future.

No co-authors to show.

All Works

5 of 5 papers shown
#Work
1
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021411
2
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
3 2021213
4 202143
5 20244

About Alex Phillips

Alex Phillips is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Surgery, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 5 papers that have together received 953 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Esophageal Cancer Research and Treatment (1 paper), Respiratory Support and Mechanisms (1 paper), Gastric Cancer Management and Outcomes (1 paper) and Enhanced Recovery After Surgery (1 paper). The work is most often cited by research in Infectious Diseases (706 citations), Applied Microbiology and Biotechnology (34 citations), Internal Medicine (27 citations), Hematology (29 citations) and Oncology (48 citations). Alex Phillips has collaborated with scholars based in United Kingdom, Vietnam and Nepal. Their work appears in journals such as The Lancet, The Lancet Respiratory Medicine and British journal of surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact